ICS 2014 Scientific Podium Poster Session S41 - Neurophysiology and Bladder Dysfunction

Speakers
	Thursday 23rd October 2014
	14:30 - 16:00
	Room B8
Y Yasuhiko Igawa ICS Chair J Jerzy B Gajewski ICS Chair

15:00

#642 Clinical study on overactive bladder in male patients with Parkinson’s disease and its related motor and non-motor symptoms

Presenter: Yasushi Miyagawa

Miyagawa Y¹, Tsujimura A², Takao T³, Soda T¹, Takezawa K¹, Fukuhara S¹, Kiuchi H¹, Nonomura N¹
1. Department of Urology, Osaka University Graduate School of Medicine, 2. Department of Urology, Juntendo University School of Medicine, 3. Department of Urology, Osaka General Medical Center
Constipation, Male, Overactive Bladder, Neuropathies: Central, Motor Dysfunction

15:05

#643 Redefining refractory incontinence: Does ice water test (IWT) at one month after treatment correlate with adequacy of suppression of neurogenic detrusor overactivity (NDO) in the patients with neurogenic bladder after spinal cord injury.

Presenter: Dinesh Suman

Suman D¹
1. Isic ,New Delhi
Detrusor Overactivity, Incontinence, Urodynamics Techniques

15:10

#644 Suppression of neurogenic detrusor overactivity by glycine transporter type 2 (GlyT2) inhibitor in rats with spinal cord injury

Presenter: Tsuyoshi Yoshizawa

Yoshizawa T¹, Okada H¹, Yoshikawa S¹, Takahashi S², Yoshimura N¹
1. Department of Urology, University of Pittsburgh, 2. Department of Urology, Nihon University School of Medicine
Basic Science, Detrusor Overactivity, Pharmacology, Spinal Cord Injury

15:15

#645 Effects of phosphodiesterase type 5 inhibitor and alpha-1A/D adrenoceptor antagonist on bladder remodeling in rats with spinal cord injury

Presenter: Katsumi Kadekawa

Kadekawa K¹, Tyagi P¹, Sugaya K², Yoshimura N¹
1. University of Pittsburgh, 2. Southern Knights' Laboratory LLP
Overactive Bladder, Pharmacology, Spinal Cord Injury, Voiding Dysfunction

15:20

#646 Hyperbaric Oxygen Therapy (HBOT) Prevents Subarachnoid Haemorrhage (SAH)-Induced Apoptosis and Impaired Contractility of the Rabbit Bladder

Presenter: Tufan Tarcan

Tinay I¹, Celik O², Cadirci S³, Cevik O⁴, Oroglu B⁵, Sener G³, Tarcan T⁶
1. Marmara University School of Medicine, Dept. of Urology, 2. Duzce University School of Medicine, Dept. of Neurosurgery, 3. Marmara University, School of Pharmacy, Department of Pharmacology, Istanbul, 4. Cumhuriyet University, School of Pharmacy, Department of Biochemistry, Sivas, 5. Istanbul University Faculty of Medicine, 6. Marmara University
Animal Study, Basic Science, Neuropathies: Central

15:25

#647 LONG-TERM CALORIE RESTRICTION PROTECTS AGAINST AGE-RELATED OXIDATIVE AND FIBROTIC CHANGES IN THE RAT BLADDER

Presenter: Yasuhiko Igawa

Ito H¹, Aizawa N¹, Fujita Y², Ito M², Kojima T³, Suzuki M⁴, Homma Y⁴, Kubota Y⁵, Igawa Y¹
1. Department of Continence Medicine, The University of Tokyo Graduate School of Medicine, 2. Molecular Gerontology, Research Team for Mechanism of Aging, Tokyo Metropolitan Institute of Gerontology, 3. Health Science Center, Toyohashi University of Technology, 4. Department of Urology, The University of Tokyo Graduate School of Medicine, 5. Department of Urology, Yokohama City University Graduate School of Medicine
Animal Study, Basic Science, Detrusor Hypocontractility, Physiology, Molecular Biology

15:35

#648 Underactive bladder in obese-prone rats fed a high fat diet

Presenter: Nazema Y Siddiqui

Siddiqui N Y¹, Dieter A A¹, Amundsen C L¹, Brooks J M², Degoski D J², Fraser M O³
1. Duke University Medical Center, Durham, NC, 2. Institute for Medical Research, Durham, NC, 3. Duke University and Durham Veteran's Affairs Medical Centers, Institute for Medical Research, Durham, NC
Animal Study, Basic Science, Underactive Bladder, Physiology, Overactive Bladder

15:40

#649 Clinical and quality of life outcomes in male non-neurogenic overactive bladder managed with intra-detrusor Botulinum toxin type A: an 8 year experience

Presenter: Vincent Tse

Losco G¹, Habashy D¹, Tse V¹, Collins R¹, Chan L¹
1. Concord Repatriation General Hospital, Sydney, Australia
Detrusor Overactivity, Male, Quality of Life (QoL), Overactive Bladder, Incontinence

15:45

#650 Therapeutic efficacy and Safety of intravesical onabotulinumtoxinA 100 units injection on elderly patients with chronic central nervous system lesions and overactive bladder refractory to antimuscarinic therapy

Presenter: Chun-Hou Liao

Liao C¹, Hung S², Jiang Y³, Kuo H³
1. Department of Urology, Cardinal Tien Hospital and School of Medicine, Fu-Jen Catolic University, New Taipei, 2. Department of Urology, Far Eastern Memorial Hospital, New Taipei, Taiwan, 3. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
Overactive Bladder, Neuropathies: Central, Pharmacology

Content Visitors (staff only)

Neurophysiology and Bladder Dysfunction

Scientific Podium Poster Session S41

Session Schedule

Comments

Chat